(Q36816053)

16 August 2017

1 reference

title

Interleukins: biological properties and therapeutic potential (English)

1 reference

16 August 2017

Interleukins: Biological Properties and Therapeutic Potential (English)

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

15 November 2022

author name string

R. E. Elmslie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748980

15 November 2022

S. W. Dow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748980

15 November 2022

G. K. Ogilvie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748980

15 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1748980

15 November 2022

publication date

1 September 1991

1 reference

full work available at URL

16 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1939-1676.1991.tb03135.x

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1939-1676.1991.tb03135.x/fullpdf

15 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Journal of Veterinary Internal Medicine

15 November 2022

published in

1 reference

16 August 2017

volume

5

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

283-293

1 reference

Why should internists be interested in interleukin-1?

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB03135.X

Acquired immunodeficiency syndrome: epidemiology, virology, and immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB03135.X

Granulocyte/macrophage-, megakaryocyte-, eosinophil- and erythroid-colony-stimulating factors produced by mouse spleen cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB03135.X

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB03135.X

B-cell stimulatory factor-1/interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB03135.X

Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB03135.X

21 January 2018

Lymphokines

1

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The role of IL-10 in crossregulation of TH1 and TH2 responses

15 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

15 November 2022

Interleukin-1.

5

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Secretory products of macrophages

15 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 1 and T cell activation

15 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The basis for the immunoregulatory role of macrophages and other accessory cells

15 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Cytokines involved in the generation of cytolytic effector T lymphocytes

15 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Biotherapy: the fourth modality of cancer treatment

15 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Current concepts: immunology. Monocytes and macrophages

15 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

A cell cycle analysis of murine lymphokines

15 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Secretory products of macrophages and their physiological functions

15 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine

15 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

15 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

15 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Identification of interleukin-1 in equine osteoarthritic joint effusions

15 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

15 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

15 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The pancreatic islets in diabetes

15 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation

15 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Regulation of natural killer activity

15 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

15 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Immunotherapy of rheumatic diseases--practice and prospects

15 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media

15 November 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

T cell growth factor receptors. Quantitation, specificity, and biological relevance

15 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Induction of T cell proliferation and cytotoxicity by lymphokines

15 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo

15 November 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells

15 November 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The role of natural killer cells in human disease

15 November 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo

15 November 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Local conditions in the host influence immunotherapy with interleukin-2 and LAK cells

15 November 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Immunoregulation of carcinogenesis: past, present, and future

15 November 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Effects of biological response modifiers on effector cells with cytotoxic activity against tumors

15 November 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

15 November 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

15 November 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease

15 November 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin

15 November 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Myocardial toxic effects during recombinant interleukin-2 therapy

15 November 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells

15 November 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The role of biological response modifiers in metastatic renal cell carcinoma

15 November 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

15 November 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity

15 November 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Sequence dependence of administration of human recombinant tumor necrosis factor and interleukin-2 in murine tumor therapy

15 November 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Combining chemotherapy with biological response modifiers in treatment of cancer

15 November 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Biological response modifiers in cancer therapeutics: potentialities and limitations

15 November 2022

73

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Adoptive immunotherapy in combination with chemotherapy for cancer treatment.

15 November 2022

75

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis

15 November 2022

76

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

15 November 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome

15 November 2022

79

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

15 November 2022

81

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS

15 November 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The human hematopoietic colony-stimulating factors

15 November 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Cell stimulation by haemopoietic lymphokines

15 November 2022

87

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Analysis of murine megakaryocyte colony size and ploidy: effects of interleukin-3.

15 November 2022

92

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The molecular control of blood cell development

15 November 2022

93

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Tumor-promoting phorbol esters stimulate the proliferation of interleukin-3 dependent cells

15 November 2022

95

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Molecular cloning of cDNA for murine interleukin-3.

15 November 2022

97

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study

15 November 2022

99

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

15 November 2022

101

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Hemopoietic colony stimulating factors. A physiological and pharmacological role in fighting infection?

15 November 2022

104

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

15 November 2022

105

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

15 November 2022

106

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture

15 November 2022

107

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1

15 November 2022

108

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The role of the colony-stimulating factors in resistance to acute infections

15 November 2022

111

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Lymphokine receptor interactions.

15 November 2022

114

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Application of a human T cell line derived from a Sézary syndrome patient for human interleukin 4 assay.

15 November 2022

115

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation

15 November 2022

116

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor

15 November 2022

117

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

15 November 2022

118

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.

15 November 2022

121

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

15 November 2022

125

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

IL-4 inhibits the expression of IL-8 from stimulated human monocytes

15 November 2022

126

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells

15 November 2022

127

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties

15 November 2022

128

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication

15 November 2022

129

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion

15 November 2022

130

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells

15 November 2022

131

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

IL-4, but not IL-5, can act synergistically with B cell activating factor (BCAF) to induce proliferation of resting B cells

15 November 2022

132

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Recombinant human interleukin 5 is a selective activator of human eosinophil function

15 November 2022

133

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts

15 November 2022

136

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

15 November 2022

137

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

IL-6 activity in feline infectious peritonitis

15 November 2022

139

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Synergistic interaction between interleukin-6 and interleukin-3 in support of stem cell proliferation in culture

15 November 2022

140

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

15 November 2022

144

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system

15 November 2022

146

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 7 production and function in stromal cell-dependent B cell development

15 November 2022

147

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Stimulation of B-cell progenitors by cloned murine interleukin-7

15 November 2022

148

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta

15 November 2022

149

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Recombinant interleukin-7 supports the growth of normal B lymphocyte precursors

15 November 2022

150

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones.

15 November 2022

151

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells

15 November 2022

152

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood

15 November 2022

155

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 7 is a T-cell growth factor

15 November 2022

157

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation

15 November 2022

159

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

15 November 2022

160

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1)

15 November 2022

161

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

15 November 2022

162

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8

15 November 2022

163

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin

15 November 2022

164

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines

15 November 2022

165

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin

15 November 2022

166

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis

15 November 2022

171

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Recombinant Human Interleukin-8 Is a Potent Activator of Canine Neutrophil Aggregation, Migration, and Leukotriene B4 Biosynthesis

15 November 2022

172

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

15 November 2022

173

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9)

15 November 2022

175

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

15 November 2022

176

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

15 November 2022

177

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

15 November 2022

179

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

15 November 2022

180

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

15 November 2022

181

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

15 November 2022

182

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

15 November 2022

183

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB03135.X

15 November 2022

Identifiers

1 reference

16 August 2017

1 reference